Putrescine biosynthetic process

pathway activity — cross-omics
GO:0009446Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Putrescine biosynthetic process pathway is significantly associated with the RNA expression of multiple genes, with the CCRCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are SMARCD2, CHST10, and PLG, each associated with the pathway in up to 2 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Putrescine biosynthetic process activity versus SMARCD2 in CCRCC (Pearson r = -0.38).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
CCRCCSMARCD2 →-0.191-0.090.001<.00132
CCRCCCHST10 →-0.482-0.089<.001<.00132
CCRCCPLG →+1.802+0.122<.001<.00132
CCRCCSLC35D2 →+0.257+0.090.009.00432
CCRCCZSWIM3 →-0.251-0.086<.001<.00132
CCRCCSPATA9 →-0.358-0.124<.001<.00132
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0009446 vs SMARCD2 — CCRCC

Per-sample scatter of Putrescine biosynthetic process activity vs SMARCD2 in CCRCC.

Explore this scatter interactively →

Exploration